Cibc World Markets Corp Alkermes Plc. Transaction History

Cibc World Markets Corp

  • $13.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$21.94 - $26.24 $111 Million - $133 Million
5,075,360 New
5,075,360 $133 Million
Q3 2019

Nov 12, 2019
SELL
$19.51 - $24.28 $5.92 Million - $7.37 Million
-303,600 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$21.47 - $37.33 $6.52 Million - $11.3 Million
303,600 New
303,600 $6.84 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email